Radioactive drug targets Hard-to-Treat sarcoma in early trial
Disease control
Recruiting now
This early-phase study tests a new radioactive drug, [Ac225]-RTX-2358, in 30 adults with advanced soft tissue sarcoma that has returned or not responded to prior treatment. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Partici…
Phase: PHASE1 • Sponsor: Ratio Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC